Bayer initiates phase III study to investigate aflibercept 8 mg in retinal vein occlusion
10 May 2023 | 09:59 AM Europe/Amsterdam Not intended for U.S. and UK Media Summary Global phase III QUASAR study ...
Read moreDetails10 May 2023 | 09:59 AM Europe/Amsterdam Not intended for U.S. and UK Media Summary Global phase III QUASAR study ...
Read moreDetails© 2023 earth-news.info
© 2023 earth-news.info